These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 2390772)

  • 1. Comparison of in vivo and in vitro efficacy of ceftizoxime.
    Delaney ML; Cisneros RL; Onderdonk AB
    Clin Ther; 1990; 12 Suppl C():25-30. PubMed ID: 2390772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Media- and method-dependent variation in MIC values of ceftizoxime for clinical isolates of the Bacteroides fragilis group.
    Wexler HM; Finegold SM
    Clin Ther; 1990; 12 Suppl C():13-24. PubMed ID: 2390771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Media- and method-dependent variation in MIC values of ceftizoxime for clinical isolates of the Bacteroides fragilis group.
    Wexler HM; Finegold SM
    J Chemother; 1991 Feb; 3 Suppl 2():12-9. PubMed ID: 2040893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An update on the in vitro activity of ceftizoxime and other cephalosporin/cephamycin antimicrobial agents against clinically significant anaerobic bacteria.
    Aldridge KE
    Clin Ther; 1990; 12 Suppl C():3-12. PubMed ID: 2202509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of dosing and dosing frequency on the efficacy of ceftizoxime and the emergence of ceftizoxime resistance during the early development of murine abscesses caused by Bacteroides fragilis and Enterobacter cloacae mixed infection.
    Stearne LE; Goessens WH; Mouton JW; Gyssens IC
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3605-11. PubMed ID: 17646416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of inoculum size and medium on activity of seven antimicrobial agents against Bacteroides fragilis strains.
    Wexler HM; Reeves D; Finegold SM
    Clin Ther; 1989; 11(6):828-33. PubMed ID: 2611824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multilaboratory comparison of anaerobe susceptibility results using 3 different agar media.
    Roe DE; Finegold SM; Citron DM; Goldstein EJ; Wexler HM; Rosenblatt JE; Cox ME; Jenkins SG; Hecht DW
    Clin Infect Dis; 2002 Sep; 35(Suppl 1):S40-6. PubMed ID: 12173107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the E-test for susceptibility testing of the Bacteroides fragilis group. Danish study group.
    Bremmelgaard A; Jansen JE; Justesen T; Gottschau A
    APMIS; 1994 Jun; 102(6):446-50. PubMed ID: 8068304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vitro activity of the oxa-beta-lactam LY 127935 against Bacteroides fragilis and other anaerobic gram-negative rods (author's transl)].
    Werner H; Krasemann C
    Infection; 1980; 8 Suppl 3():S 342-6. PubMed ID: 6447673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility trends of Bacteroides fragilis group isolates from Buenos Aires, Argentina.
    Fernández Canigia L; Castello L; Di Martino A; Greco G; Legaria MC; Litterio M; Predari SC; Rollet R; Rossetti A; Carloni G; Sarchi MI; Bianchini H
    Rev Argent Microbiol; 2007; 39(3):156-60. PubMed ID: 17987852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of tigecycline against Bacteroides species.
    Betriu C; Culebras E; Gómez M; Rodríguez-Avial I; Picazo JJ
    J Antimicrob Chemother; 2005 Aug; 56(2):349-52. PubMed ID: 15951353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic- and method-dependent variation in susceptibility testing results of Bacteroides fragilis group isolates.
    Aldridge KE; Sanders CV
    J Clin Microbiol; 1987 Dec; 25(12):2317-21. PubMed ID: 3480894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inducible metronidazole resistance in nim-positive and nim-negative bacteroides fragilis group strains after several passages metronidazole containing columbia agar plates.
    Schaumann R; Petzold S; Fille M; Rodloff AC
    Infection; 2005 Oct; 33(5-6):368-72. PubMed ID: 16258869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of in vitro susceptibilities of Bacteroides and Fusobacterium species in inland southern California to published patterns as a guide to empiric therapy.
    Roy I; Blomquist IK
    Clin Ther; 1993; 15(5):875-83. PubMed ID: 8269454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of ciprofloxacin's synergism with other agents by multiple in vitro methods.
    Moody JA; Gerding DN; Peterson LR
    Am J Med; 1987 Apr; 82(4A):44-54. PubMed ID: 3107380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in the in vitro inhibitory and bactericidal activity of ceftizoxime, cefoxitin, cefotetan, and penicillin G against Bacteroides fragilis group isolates. Comparison of time-kill kinetic studies with MIC values.
    Aldridge KE; Weeks LS; Stratton CW; Sanders CV
    Diagn Microbiol Infect Dis; 1990; 13(4):311-6. PubMed ID: 2076592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Susceptibility of the Bacteroides fragilis group to 10 antibiotics. Results of 4 laboratories in Austria].
    Mittermayer H; Rotter M; Riezinger F; Thiel W; Stanek G
    Zentralbl Bakteriol Mikrobiol Hyg A; 1986 Nov; 262(4):500-11. PubMed ID: 3799095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic susceptibility testing of anaerobic organisms using the agar dilution method: comparison of three techniques.
    Wexler HM; Reeves D; Finegold SM
    Clin Ther; 1988; 10(6):747-60. PubMed ID: 3219688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro activity of a combination of amoxicillin-clavulanic acid on anaerobic bacteria].
    Sedallian A; Roudon T
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):678-81. PubMed ID: 3054746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparisons of the in vitro susceptibility testing results for garenoxacin using six different national methods: report from the garenoxacin international bridging study.
    Jones RN; Gordon KA; Biedenbach DJ
    J Antimicrob Chemother; 2004 Feb; 53(2):258-65. PubMed ID: 14729758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.